MedPath

The Effect of Triptorelin on Electrocardiogram

Phase 2
Recruiting
Conditions
precocious puberty.
Precocious puberty
Registration Number
IRCT20190314043051N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Children with precocious puberty
Referring to Endocrinology Clinic of Tabriz Children Hospital

Exclusion Criteria

Having any type of previous cardiac disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QRS interval duration in electrocardiogram. Timepoint: Before the intervention and 6, 12, and 18 weeks after the starting of gonadotropin releasing hormone agonists. Method of measurement: Electrocardiography.;PR interval duration in electrocardiogram. Timepoint: Before the intervention and 6, 12, and 18 weeks after the starting of gonadotropin releasing hormone agonists. Method of measurement: Electrocardiography.;QT interval duration in electrocardiogram. Timepoint: Before the intervention and 6, 12, and 18 weeks after the starting of gonadotropin releasing hormone agonists. Method of measurement: Electrocardiography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath